02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 4.1.7 Liver.<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number<br />

indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Wu<br />

1998<br />

[41]<br />

Taiwan<br />

RCT<br />

Consecutive pts with<br />

elective liver resection.<br />

90% malignant diagnoses.<br />

Randomisation type not<br />

given.<br />

n=127<br />

I: Cephazolin 1 g iv every 6 h<br />

and gentamicin 80 mg every<br />

8 h for 7 days beginning immediately<br />

after operation (n=65)<br />

C: No ab (n=62) Infective complications<br />

defined as positive<br />

culture from infected<br />

side<br />

I: 15 pts (23%)<br />

C: 14 pts (23%)<br />

Intraabdominal abscesses<br />

I: 8 pts<br />

C: 5 pts<br />

High<br />

Groups well matched.<br />

Unique study. Clean<br />

surgery but reticuloendothelial<br />

system<br />

reduced<br />

ab = Antibiotics; C = Control group; h = Hours; I = Intervention group; n = Number<br />

of patients; pts = Patients; RCT = Randomised controlled trial<br />

Table 4.1.8 Pancreas.<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study<br />

design<br />

Population<br />

characteristics<br />

Intervention<br />

Method<br />

Number indi<strong>vid</strong>uals<br />

Control<br />

Number indi<strong>vid</strong>uals<br />

Results<br />

Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Schwartz<br />

2001<br />

[42]<br />

Germany<br />

RCT<br />

Pts with pancreatic<br />

cancer or chronic<br />

pancreatitis. Major<br />

surgery.<br />

n=28<br />

I: Ofloxacin 400 mg + metronidazole<br />

0.5 g orally 2 h prior<br />

to surgery (n=15)<br />

C: Mezlocillin 4.5 g +<br />

metronidazole 0.5 g iv<br />

30 min before surgery<br />

(n=13)<br />

Post-op infection<br />

defined by CDC<br />

I: 1 pt<br />

C: 2 pts<br />

6% additional<br />

antibiotics<br />

Moderate<br />

Both pancreatic<br />

and colonic surgery<br />

C = Control group; CDC = Centre for Disease Control; I = Intervention group;<br />

iv = Intravenous; n = Number of patients; pts = Patients; RCT = Randomised controlled<br />

trial<br />

120 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

121

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!